Agilent Technologies Inc. announced the Encore Multispan liquid handling system, featuring an array of unique technological advances in a single instrument. The Encore Multispan liquid handling system will enable new automation capabilities that improve every stage of the research process.
The Encore Multispan system combines innovative multispan pipetting with the reach of a built-in robotic arm and intelligent software control to deliver a new level of productivity and throughput. Using the Encore Multispan system, researchers will be able to easily automate a larger portion of their workflow and significantly expand their walkaway time.
The Encore Multispan system combines advanced liquid handling and robotics to enable true sample-to-analysis automation. Agilent’s experience in workflow automation and liquid handling has allowed for the integration of both technologies into a single platform.
The Encore Multispan liquid handling system will include the following innovations:
• A dual, multispan pipetting system provides two individual banks of multiple pipettes where each moves independently in multiple axes, delivering ultimate speed and double the throughput available today. Each pipette can address a variety of sample formats, from tubes to vials to microplates.
• An innovative and powerful software package features a 3-D simulator that provides researchers with the ability to set up, visualize, and optimize their protocols remotely and offline prior to running valuable experiments on the system.
• A built-in robotic arm provides a span of up to 21 inches off-deck with patented one-touch easy teaching that enables end-to-end workflow integrations with unprecedented range and flexibility.
The combination of these unique capabilities will provide researchers with the ability to quickly and easily automate complete workflows for a wide range of applications, including high-throughput screening, ELISA, ADME/TOX, compound management and sample-preparation workflows for genomics, proteomics, and more.
Filed Under: Drug Discovery
